Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia.

Bain EE, Shafner L, Walling DP, Othman AA, Chuang-Stein C, Hinkle J, Hanina A.

JMIR Mhealth Uhealth. 2017 Feb 21;5(2):e18. doi: 10.2196/mhealth.7030.

2.

Using Artificial Intelligence to Reduce the Risk of Nonadherence in Patients on Anticoagulation Therapy.

Labovitz DL, Shafner L, Reyes Gil M, Virmani D, Hanina A.

Stroke. 2017 May;48(5):1416-1419. doi: 10.1161/STROKEAHA.116.016281. Epub 2017 Apr 6.

3.

The α7 Nicotinic Agonist ABT-126 in the Treatment of Cognitive Impairment Associated with Schizophrenia in Nonsmokers: Results from a Randomized Controlled Phase 2b Study.

Haig G, Wang D, Othman AA, Zhao J.

Neuropsychopharmacology. 2016 Nov;41(12):2893-2902. doi: 10.1038/npp.2016.101. Epub 2016 Jun 20.

4.

Let Visuals Tell the Story: Medication Adherence in Patients with Type II Diabetes Captured by a Novel Ingestion Sensor Platform.

Browne SH, Behzadi Y, Littlewort G.

JMIR Mhealth Uhealth. 2015 Dec 31;3(4):e108. doi: 10.2196/mhealth.4292.

5.

Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy.

Choo PW, Rand CS, Inui TS, Lee ML, Cain E, Cordeiro-Breault M, Canning C, Platt R.

Med Care. 1999 Sep;37(9):846-57.

PMID:
10493464
6.

Adherence profiles and therapeutic responses of treatment-naive HIV-infected patients starting boosted atazanavir-based therapy in the ANRS 134-COPHAR 3 trial.

Parienti JJ, Barrail-Tran A, Duval X, Nembot G, Descamps D, Vigan M, Vrijens B, Panhard X, Taburet AM, Mentré F, Goujard C.

Antimicrob Agents Chemother. 2013 May;57(5):2265-71. doi: 10.1128/AAC.02605-12. Epub 2013 Mar 4.

7.

Rationale and design of a randomized controlled trial of directly observed hepatitis C treatment delivered in methadone clinics.

Litwin AH, Berg KM, Li X, Hidalgo J, Arnsten JH.

BMC Infect Dis. 2011 Nov 12;11:315. doi: 10.1186/1471-2334-11-315.

8.

Text Messaging to Improve Hypertension Medication Adherence in African Americans From Primary Care and Emergency Department Settings: Results From Two Randomized Feasibility Studies.

Buis L, Hirzel L, Dawood RM, Dawood KL, Nichols LP, Artinian NT, Schwiebert L, Yarandi HN, Roberson DN, Plegue MA, Mango LC, Levy PD.

JMIR Mhealth Uhealth. 2017 Feb 1;5(2):e9. doi: 10.2196/mhealth.6630.

9.

A comparison of measures used to describe adherence to glaucoma medication in a randomised controlled trial.

Cate H, Bhattacharya D, Clark A, Holland R, Broadway DC.

Clin Trials. 2015 Dec;12(6):608-17. doi: 10.1177/1740774515592636. Epub 2015 Jul 16.

PMID:
26183437
10.

Strong relationship between oral dose and tenofovir hair levels in a randomized trial: hair as a potential adherence measure for pre-exposure prophylaxis (PrEP).

Liu AY, Yang Q, Huang Y, Bacchetti P, Anderson PL, Jin C, Goggin K, Stojanovski K, Grant R, Buchbinder SP, Greenblatt RM, Gandhi M.

PLoS One. 2014 Jan 8;9(1):e83736. doi: 10.1371/journal.pone.0083736. eCollection 2014.

11.

Mobile Health Medication Adherence and Blood Pressure Control in Renal Transplant Recipients: A Proof-of-Concept Randomized Controlled Trial.

McGillicuddy JW, Gregoski MJ, Weiland AK, Rock RA, Brunner-Jackson BM, Patel SK, Thomas BS, Taber DJ, Chavin KD, Baliga PK, Treiber FA.

JMIR Res Protoc. 2013 Sep 4;2(2):e32. doi: 10.2196/resprot.2633.

12.

A Randomized Trial to Assess the Efficacy and Safety of ABT-126, a Selective α7 Nicotinic Acetylcholine Receptor Agonist, in the Treatment of Cognitive Impairment in Schizophrenia.

Haig GM, Bain EE, Robieson WZ, Baker JD, Othman AA.

Am J Psychiatry. 2016 Aug 1;173(8):827-35. doi: 10.1176/appi.ajp.2015.15010093. Epub 2016 Mar 4.

PMID:
26940805
13.

Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice.

Farmer KC.

Clin Ther. 1999 Jun;21(6):1074-90; discussion 1073. Review.

PMID:
10440628
14.

The Impact of Text Messaging on Medication Adherence and Exercise Among Postmyocardial Infarction Patients: Randomized Controlled Pilot Trial.

Pandey A, Krumme A, Patel T, Choudhry N.

JMIR Mhealth Uhealth. 2017 Aug 3;5(8):e110. doi: 10.2196/mhealth.7144.

16.

Modeling the impact of modified directly observed antiretroviral therapy on HIV suppression and resistance, disease progression, and death.

Kagay CR, Porco TC, Liechty CA, Charlebois E, Clark R, Guzman D, Moss AR, Bangsberg DR.

Clin Infect Dis. 2004 Jun 1;38 Suppl 5:S414-20.

PMID:
15156432
17.

A randomized pilot study of the efficacy and safety of ABT-089, a novel α4β2 neuronal nicotinic receptor agonist, in adults with attention-deficit/hyperactivity disorder.

Bain EE, Apostol G, Sangal RB, Robieson WZ, McNeill DL, Abi-Saab WM, Saltarelli MD.

J Clin Psychiatry. 2012 Jun;73(6):783-9. doi: 10.4088/JCP.10m06719.

PMID:
22795204
18.

A Spanish pillbox app for elderly patients taking multiple medications: randomized controlled trial.

Mira JJ, Navarro I, Botella F, Borrás F, Nuño-Solinís R, Orozco D, Iglesias-Alonso F, Pérez-Pérez P, Lorenzo S, Toro N.

J Med Internet Res. 2014 Apr 4;16(4):e99. doi: 10.2196/jmir.3269.

19.

A qualitative examination of the indirect effects of modified directly observed therapy on health behaviors other than adherence.

Bradley-Ewing A, Thomson D, Pinkston M, Goggin KJ.

AIDS Patient Care STDS. 2008 Aug;22(8):663-8. doi: 10.1089/apc.2007.0190.

20.

Randomized control trial of peer-delivered, modified directly observed therapy for HAART in Mozambique.

Pearson CR, Micek MA, Simoni JM, Hoff PD, Matediana E, Martin DP, Gloyd SS.

J Acquir Immune Defic Syndr. 2007 Oct 1;46(2):238-44.

Supplemental Content

Support Center